GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (XCNQ:IMCC) » Definitions » Shiller PE Ratio

IM Cannabis (XCNQ:IMCC) Shiller PE Ratio : (As of May. 04, 2024)


View and export this data going back to 1980. Start your Free Trial

What is IM Cannabis Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


IM Cannabis Shiller PE Ratio Historical Data

The historical data trend for IM Cannabis's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Shiller PE Ratio Chart

IM Cannabis Annual Data
Trend Apr13 Apr14 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IM Cannabis Quarterly Data
Jan19 Apr19 Jul19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of IM Cannabis's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IM Cannabis's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IM Cannabis's Shiller PE Ratio falls into.



IM Cannabis Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

IM Cannabis's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, IM Cannabis's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.58/129.4194*129.4194
=-0.580

Current CPI (Dec. 2023) = 129.4194.

IM Cannabis Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201210 -2.000 97.595 -2.652
201301 -20.000 97.158 -26.641
201304 -104.000 98.107 -137.193
201307 -2.000 98.557 -2.626
201310 -2.000 98.536 -2.627
201401 -2.000 98.692 -2.623
201404 -2.886 100.023 -3.734
201407 -2.000 100.520 -2.575
201410 -2.000 100.176 -2.584
201501 -2.000 98.604 -2.625
201604 0.028 100.947 0.036
201607 0.000 101.524 0.000
201610 0.000 101.988 0.000
201701 0.000 102.456 0.000
201704 -0.400 103.167 -0.502
201707 -0.031 103.278 -0.039
201710 -0.201 104.070 -0.250
201801 -0.396 104.578 -0.490
201804 -1.773 105.708 -2.171
201807 -0.400 106.324 -0.487
201901 -0.077 106.200 -0.094
201904 0.000 107.818 0.000
201907 -0.002 108.250 -0.002
201912 0.000 108.420 0.000
202003 -0.100 108.902 -0.119
202006 -5.200 108.767 -6.187
202009 0.228 109.815 0.269
202012 -4.868 109.897 -5.733
202103 -0.600 111.754 -0.695
202106 -2.300 114.631 -2.597
202109 -1.800 115.734 -2.013
202112 -1.890 117.630 -2.079
202203 -0.140 121.301 -0.149
202206 -0.890 125.017 -0.921
202209 -2.290 125.227 -2.367
202212 -8.072 125.222 -8.343
202303 0.030 127.348 0.030
202306 -0.260 128.729 -0.261
202309 -0.490 129.860 -0.488
202312 -0.580 129.419 -0.580

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IM Cannabis  (XCNQ:IMCC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


IM Cannabis Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of IM Cannabis's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IM Cannabis (XCNQ:IMCC) Business Description

Traded in Other Exchanges
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.